Additional file 2: of Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
Final dose toxicity curves and 95 % prediction intervals for every CRM method + 10 percentage points. Legend: The predicted probabilities of experiencing a DLT and corresponding 95 % prediction intervals for each prior skeleton + 10 % approach used in the extended CRM method after the MTD has been determined for the AZD3514 data. (ZIP 678 kb)
创建时间：
2016-12-14
